“NeuroVanguard”: a contemporary strategy in neuromonitoring for severe adult brain injury patients
Authors (first, second and last of 4)
![](https://media.springernature.com/w290h158/springer-static/image/art%3A10.1186%2Fs13054-024-04893-4/MediaObjects/13054_2024_4893_Fig1_HTML.png)
Collection
Prof. Mirski’s laboratory research involves the investigation of the subcortical mechanisms of seizure propagation and cortical synchrony. The lab directs major effort toward the development of methodologies for seizure inhibition via site-specific subcortical electrical stimulation. The principal finding of his research—identification of synaptically linked subcortical elements important in seizure propagation—has led to FDA-sanctioned Phase III clinical trials of targeted thalamic stimulation in patients with intractable seizures. Dr. Mirski also conducts primary research in the treatment of brain edema, ICU sedation and acute stroke.